News Archive

Truvian Sciences Raises $105M Series C to Fund Development of Point-of-Care Testing Platform

Medtech Insight- February 24, 2021

“This is really about disrupting the way that industry is structured today,” CEO Jeff Hawkins said. “One of the core tenets to the approach we took to even developing this technology was [that] we wanted the point-of-care test to have...... Read more

...

No More Waiting for Central Lab Results: Truvian Raises $105M

Timmerman Report- February 24, 2021

Compact and fully automated point-of-care blood testing solutions will certainly have a more prominent role as consumers demand the convenience of accessing test results at a local pharmacy, an on-site clinic, at work, or at a physician's office.... Read more

...

Truvian Raises $105M, Plans to Submit Benchtop Blood-Testing Tech to FDA

MedCityNews- February 24, 2021

Unlike Theranos, Truvian is seeking regulatory clearance from the outset, and bringing in laboratory experts to validate its approach. As it approaches its FDA submission, Truvian plans to ramp up clinical trials and manufacturing of cartridges for its device.... Read more

...

Truvian Sciences Raises More Than $105M in Series C Financing

FinSMEs- February 24, 2021

The company intends to use the funds to advance development of its automated benchtop blood testing system, paving the way to submit the device for U.S. Food and Drug Administration (FDA) clearance, and to scale its team in preparation for...... Read more

...

Truvian Closes $105M Series C Financing Round

360Dx- February 24, 2021

Truvian announced on Wednesday that it has closed a $105 million Series C financing round, bringing the total amount the company has raised to date to more than $150 million.... Read more

...
1 2 3 8